ࡱ> =?< bjbj99 . [{_[{_  GGGGG[[[[ g[.^^^Z.\.\.\.\.\.\.$03.G^^^^^.GG.^RGGZ.^Z.",.'o.,F..0.,6!4p!4,.!4G.4^^^^^^^..N:^^^.^^^^!4^^^^^^^^^ : MU PT 6620 Case Management: Acute & Chronic Medical & Surgical Conditions General Principals of Pharmacology A. Pharmacokinetics - the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. What the body does to the drug. Route of Administration Enteral = alimentary canal Oral: subject to first pass: portal vein to the liver Sublingual: directly to venous return. No first pass e.g. nitroglycerin Buccal: directly to venous return. No first pass Rectal: given if vomiting or unconscious. Poor absorption Advantages: Non invasive; Ease of drug administration; Mouth and the GI tract have a rich blood supply for pancorporeal dispersal of the medication; Avoids large fluctuations in drug delivery Disadvantages: Drugs must be lipid soluble; Drugs can be irritating to the mucosa of the mouth and the gut. Parenteral = outside alimentary canal IV intramuscular (IM): vaccines, botulinum (prolonged release into venous circulation) subcutaneous (SQ): insulin, Norplant (contraceptive) transdermal patch: e.g. nitro patch or fentanyl-opiod patch transdermal iontophoresis and phonophoresis: lidocaine or dexamethasone are driven through dermal layer to local tissue intrathecal, epidural: for administering analgesic, anesthetic, or antispasmodic (botulinum) Advantages: Fast delivery of the medications (IV, inhalation); Efficient maintenance of therapeutic ranges (IV); More predictable; Can give large quantities of medication Disadvantage: Invasive Topical- creams, eye/ear drops, nasal sprays (NS), inhalers (INH) (sometimes topical is lumped under parenteral) Bioavailability: amount of drug that actually makes it to the intended downstream target. Influenced by route of administration and how easily it can cross cell membrane barriers (size, shape, charge, lipid soluble or protein-bound) Metabolism / Biotransformation: deactivation by the liver, the Great Detoxifier (hydrolysis, oxidation, reduction, conjugation) Elimination / Excretion: primarily by kidneys. minor roles played by: GI tract (bile salts), lungs (inhaled drugs), sweating, saliva, breast milk B. Pharmacodynamics What the drug does to the body C. Pharmacotherapeutics - is using drug therapy to stimulate or depress certain biochemical or physiological functions in our patient to provide relief of symptoms or ideally to favorably alter the course of their disease. Therapeutic Index (TI) = Toxic dose / Effective dose This indicates the relative safety of a drug. For example: Acetominophen 27 Valium 3 Methotrexate, vincristine 1 Digitalis and Coumadin also have low (narrow) TI. Frequent blood draws needed to monitor levels. E. Mechanism of Action 1. Agonist - drug mimics an endogenous substance that would normally stimulate a receptor 2. Antagonist - drug which binds a receptor site, doesn't stimulate it, but does block other substances from stimulating it F. Drug Nomenclature 1. Chemical name - example - n-acetyl-para-amino phenol 2. Generic drug name - example acetaminophen. The FDA catalogs the drug by its generic name 3. Trade name / Brand name- example Tylenol. This is the name the manufacturer gives to the drug that distinguishes it from the same (generic) drug made by other drug companies. G. Off-label use A prescription drug may be prescribed for a purpose / diagnosis that is not approved by the FDA. No clinical trials have been done to study this off-label use. Example: gabapentin, Neruontin is an antiseizure medicine. It is commonly prescribed off-label for the pain of peripheral neuropathy. References: Bill Morrissey PharmD R.Ph, Kilgores Medical Pharmacy, Columbia MO Ciccone, C. (2007). Pharmacology in Rehabilitation. (4th ed.). Philadelphia: F. A. Davis Company.  IJm  # % 0 S ]  " joe$)1}}~+,|ŻŻٱū١ٍ h%DmCJH*h%Dm6B*CJ]phh%DmB*CJph h0gCJh%Dm5>*CJ\h^h%Dm5>*h%Dmh%Dm5CJ\ h%Dm>*CJ h%DmCJ h%DmCJ h%Dm5CJ\h0g5CJ\hM5CJ\/Jmn  7 o % S y |  A   L6 & Fp^p & F & F & F$a$Ode}~}~++,8^ ^` & Fh^h8| & F,1h/ =!`"`#$`% w2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@6666_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH ::  Heading 1$@&5\>@>  Heading 2$@& 5>*\88  Heading 3$@&CJ(DA D Default Paragraph FontViV  Table Normal :V 44 la (k (No List DC@D Body Text Indent ^HRH Body Text Indent 2 ^B>@B Title$a$5CJOJQJ\^JLS@"L Body Text Indent 3 ^CJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVqu ѡ{5kP?O&Cנ Aw0kPo۵(h[5($=CVs]mY2zw`nKDC]j%KXK 'P@$I=Y%C%gx'$!V(ekڤք'Qt!x7xbJ7 o߼W_y|nʒ;Fido/_1z/L?>o_;9:33`=—S,FĔ觑@)R8elmEv|!ո/,Ә%qh|'1:`ij.̳u'k CZ^WcK0'E8S߱sˮdΙ`K}A"NșM1I/AeހQתGF@A~eh-QR9C 5 ~d"9 0exp<^!͸~J7䒜t L䈝c\)Ic8E&]Sf~@Aw?'r3Ȱ&2@7k}̬naWJ}N1XGVh`L%Z`=`VKb*X=z%"sI<&n| .qc:?7/N<Z*`]u-]e|aѸ¾|mH{m3CԚ .ÕnAr)[;-ݑ$$`:Ʊ>NVl%kv:Ns _OuCX=mO4m's߸d|0n;pt2e}:zOrgI( 'B='8\L`"Ǚ 4F+8JI$rՑVLvVxNN";fVYx-,JfV<+k>hP!aLfh:HHX WQXt,:JU{,Z BpB)sֻڙӇiE4(=U\.O. +x"aMB[F7x"ytѫиK-zz>F>75eo5C9Z%c7ܼ%6M2ˊ 9B" N "1(IzZ~>Yr]H+9pd\4n(Kg\V$=]B,lוDA=eX)Ly5ot e㈮bW3gp : j$/g*QjZTa!e9#i5*j5ö fE`514g{7vnO(^ ,j~V9;kvv"adV݊oTAn7jah+y^@ARhW.GMuO "/e5[s󿬅`Z'WfPt~f}kA'0z|>ܙ|Uw{@՘tAm'`4T֠2j ۣhvWwA9 ZNU+Awvhv36V`^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!g theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]   8 8@0(  B S  ?5: ,6NR2>,7NR33 I7%S|c c +,8 Ic c +,V:D_9?+,DD5$%22 *Dx#PFv(aZRSRoot Entry Fo@1TableM4WordDocument. SummaryInformation(,DocumentSummaryInformation84CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q